GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas

Name: GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas
License: Public Domain

Candel Therapeutics, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

glioma, malignant

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417537
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.